These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Translational science: a view from a biotechnology investor. Klausner R Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715 [No Abstract] [Full Text] [Related]
6. Tough times set to continue for US biotech start-ups. Lehrman S Nature; 1999 Jan; 397(6716):191. PubMed ID: 9930684 [No Abstract] [Full Text] [Related]
8. French geneticists raise worries over use of new genome funds. Butler D Nature; 1999 May; 399(6733):185-6. PubMed ID: 10353229 [No Abstract] [Full Text] [Related]
9. New law to boost French biotech industry. Louët S Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900 [No Abstract] [Full Text] [Related]
10. French research minister targets IT and biotech. McCabe H Nature; 2000 May; 405(6783):106. PubMed ID: 10821237 [No Abstract] [Full Text] [Related]
11. Japanese council urges reform of funding system. Triendl R Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656 [No Abstract] [Full Text] [Related]
12. Funding bonanza for astronomy and biotech in Australia. Pockley P Nature; 2001 Aug; 412(6850):846. PubMed ID: 11528440 [No Abstract] [Full Text] [Related]
13. BIO 2006 Annual International Convention. The expanding biotech industry of France. Zarkowska T IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302 [No Abstract] [Full Text] [Related]
15. Increasing number of companies found ineligible for SBIR funding. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384 [No Abstract] [Full Text] [Related]
16. Putting a price on biotechnology. Stewart JJ; Allison PN; Johnson RS Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634 [No Abstract] [Full Text] [Related]